DAVIS, Calif., Jan. 6, 2014 /PRNewswire/ -- Marrone Bio Innovations, Inc. (MBI) [NASDAQ: MBII], a leading global provider of bio-based pest management and plant health products, is wrapping up 2013 on a significant high note. The company is announcing that it has passed the 1,000,000 treated acre milestone in the U.S. for its biopesticide products, Grandevo® bioinsecticide and Regalia® and Regalia® Rx biofungicides.
Hector Absi, MBI's Senior Vice President, Commercial Operations, puts the accomplishment in perspective, "Reaching the million acre level validates that our products continue to bring value to growers across the US. Most of these acres are in high value specialty crops, but also includes acres of our recent launch of Regalia Rx in row crops. It confirms that our products are meeting the demands of the marketplace and are being included in growers' standard spray programs year after year."
However, he goes on to add that a new product introduction in 2013 did help push them over the top. "We saw a significant increase in treated acres this year with the limited introduction of Regalia Rx in the corn and soybean markets. Those acres combined with the growing number of Florida citrus acres treated with Grandevo bioinsecticide for Asian citrus psyllid provided the final push we needed to get to 1,000,000 acres."
With increased distribution for Regalia Rx in the Midwest and the introduction of a new insecticide planned for 2014 Absi provides this final comment, "these achievements continue to give us confidence that we can deliver against our objectives and continue to meet the needs of growers with a complete portfolio of innovative biological solutions."
About Marrone Bio Innovations
Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental, and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements relating to the introduction of products. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the difficulty in predicting the outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the in the Form 10-Q that the Company filed with the Securities and Exchange Commission on November 8, 2013.
SOURCE Marrone Bio Innovations
